Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile

Enquire | Email | Print

ISBN: GDME3859D
Published Date: Feb, 2014
Format: PDF
No of Pages: 111
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

Summary

Agilent Technologies, Inc. (Agilent) is one of the world's largest measurement companies. It provides bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronic industries. The company operates through four reportable business units, namely, Life Sciences segment, Chemical Analysis segment, Electronic Measurement segment and Diagnostics and Genomics segment. Its electronic and bio-analytical measurement business is supported by its central research group, Agilent Technologies Research Laboratories (Agilent Labs). It has a presence in more than 100 countries. It operates in the US, Canada, Japan, China, Australia and the UK. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Agilent Technologies, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 8
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 9
Agilent Technologies, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 10
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 11
Agilent Technologies, Inc., Medical Equipment, Deal Details 16
Asset Purchase 16
Dako To Acquire Intellectual Property Rights From System Dynamics 16
Agilent Technologies Acquires Assets From Eurofins 17
Venture Financing 18
Lab901 Secures US$4 Million In Equity Financing 18
Lab901 Secures US$7 Million In Equity Financing 20
Private Equity 22
Linden Acquires Hycor Biomedical From Agilent Technologies 22
Partnerships 23
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 23
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 24
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 25
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 26
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 27
Agilent Enters Into Research Agreement With Chungnam National University 28
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 29
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 30
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 31
Agilent Technologies Enters Into Research Agreement With Ameritox 32
Advion Enters Into Technology Integration Agreement With Agilent Technologies 33
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 34
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 35
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 36
Dako Enters Into Co-Development Agreement With Amgen 37
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 38
Dako Enters Into Co-Development Agreement With Amgen 39
Dako Enters Into Co-Development Agreement With Bristol-Myers 40
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 41
Dako Denmark Enters Into Co-Development Agreement With Epitomics 42
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 43
Dako Enters Into Distribution Agreement With BioPorto 44
Agilent Technologies Enters Into Collaboration With Wyss Institute for Biologically Inspired Engineering at Harvard University 45
Dako Enters Into Agreement With Quintiles Transnational 47
Royal Philips Electronics Signs An Agreement With Dako 48
Dako Enters Into An Agreement With Omnyx 49
Agilent Technologies Enters Into Co-Marketing Agreement With Integrated DNA Technologies 50
BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries 51
AstraZeneca Enters Into Co-Development Agreement With Dako Denmark 52
Dako Denmark Enters Into An Agreement With OSI Pharma 53
Dako Enters Into Collaboration Agreement With Genentech 54
Advion BioSystems Signs An Agreement With Agilent Technologies 55
Millipore Enters Into Co-Development Agreement With Agilent Technologies 56
Dako Enters Into Co-Development Agreement With Bristol-Myers 57
Agendia Enters Into Co-Development Agreement With Agilent Technologies 58
Accelrys And Agilent Technologies Enter Into An Agreement 59
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 60
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 61
Debt Offering 62
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 62
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 64
Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For US$250 Million 66
Agilent Technologies Completes Public Offering Of 5% Senior Notes For US$500 Million 68
Agilent Technologies Completes Public Offering Of 5.5% Senior Notes For US$500 Million 70
Agilent Technologies Completes Public Offering Of 4.45% Senior Notes For US$250 Million 72
Asset Transactions 74
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 74
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 76
Bruker Completes Acquisition Of Three Varian Product Lines From Agilent Technologies 78
Third Wave Technologies Acquires Velocity Patents From Agilent Technologies 80
Acquisition 81
Agilent Technologies To Acquire ABC Instrumentacion Analitica 81
Leica Biosystems Completes Acquisition Of Aperio Technologies 82
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 85
Agilent Technologies Completes Acquisition Of BioSystem Development 87
Agilent Technologies Acquires P.V.R. 88
Agilent Technologies Acquires Lab901 89
Agilent Technologies Completes Acquisition Of Varian 91
TOPTICA Photonics Acquires TILL Photonics From Agilent Technologies 93
Dako Denmark Acquires InstrumeC 94
Agilent Technologies Acquires MTS Nano Instruments From MTS Systems 95
Agilent Technologies Acquires TILL Photonics 96
Agilent Technologies, Inc. - Key Competitors 97
Key Employees 97
Locations And Subsidiaries 100
Head Office 100
Other Locations & Subsidiaries 100
Recent Developments 103
Strategy And Business Planning 103
Nov 12, 2013: Agilent Technologies Joins Forces with Baylor College of Medicine to Provide Customized CGH Microarrays for Cancer, Prenatal and Postnatal Research 103
Sep 19, 2013: Agilent Technologies to Separate Into Two Industry-Leading Public Companies 103
Mar 07, 2013: Agilent Technologies And Applied Proteomics Will Collaborate To Maximize Capabilities Of Highly Multiplexed Protein Assays 104
Financial Announcements 105
Nov 14, 2013: Agilent Technologies Reports Fourth-Quarter 2013 Results 105
Aug 14, 2013: Agilent Technologies Reports Third-Quarter 2013 Results 105
May 14, 2013: Agilent Reports Revenue Of $1.7 Billion In Q2 Fiscal 2013 106
Feb 14, 2013: Agilent Technologies Reports First-Quarter 2013 Results 106
Corporate Communications 107
Feb 07, 2014: Agilent Technologies Names Guillermo Gualino as Vice President and Treasurer 107
Dec 17, 2013: Agilent Technologies Appoints Fred Strohmeier Agilent Senior VP and President of Life Sciences and Diagnostics Group 107
Sep 19, 2013: Agilent Technologies Names Robert Cantrell as Vice President and Treasurer 108
Legal and Regulatory 108
Oct 24, 2013: Agilent Technologies Names Massachusetts Eye and Ear Infirmary as Certified Service Provider for Next-Generation Sequencing and aCGH Solutions 108
Government and Public Interest 109
Jan 03, 2014: Agilent Technologies to Present at 32nd Annual J.P. Morgan Healthcare Conference 109
Aug 27, 2013: Agilent Technologies to Present at Morgan Stanley Global Healthcare Conference 109
Product News 109
Oct 22, 2013: Agilent Technologies SureSelect Target Enrichment Now Available for Ion Proton Next-Generation Sequencing Systems 109
Feb 20, 2013: Agilent Technologies Launches Genomic DNA ScreenTape 110
Other Significant Developments 110
Sep 19, 2013: Agilent Technologies Announces Cash Dividend of 12 Cents per Share 110
Appendix 111
Methodology 111
About GlobalData 111
Contact Us 111
Disclaimer 111

List of Tables

Agilent Technologies, Inc., Medical Equipment, Key Facts, 2013 1
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Agilent Technologies, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 7
Agilent Technologies, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 8
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 9
Agilent Technologies, Inc., Deals By Market, 2008 to YTD 2014 10
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 11
Dako To Acquire Intellectual Property Rights From System Dynamics 16
Agilent Technologies Acquires Assets From Eurofins 17
Lab901 Secures US$4 Million In Equity Financing 18
Lab901 Secures US$7 Million In Equity Financing 20
Linden Acquires Hycor Biomedical From Agilent Technologies 22
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 23
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 24
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 25
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 26
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 27
Agilent Enters Into Research Agreement With Chungnam National University 28
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 29
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 30
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 31
Agilent Technologies Enters Into Research Agreement With Ameritox 32
Advion Enters Into Technology Integration Agreement With Agilent Technologies 33
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 34
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 35
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 36
Dako Enters Into Co-Development Agreement With Amgen 37
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 38
Dako Enters Into Co-Development Agreement With Amgen 39
Dako Enters Into Co-Development Agreement With Bristol-Myers 40
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 41
Dako Denmark Enters Into Co-Development Agreement With Epitomics 42
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 43
Dako Enters Into Distribution Agreement With BioPorto 44
Agilent Technologies Enters Into Collaboration With Wyss Institute for Biologically Inspired Engineering at Harvard University 45
Dako Enters Into Agreement With Quintiles Transnational 47
Royal Philips Electronics Signs An Agreement With Dako 48
Dako Enters Into An Agreement With Omnyx 49
Agilent Technologies Enters Into Co-Marketing Agreement With Integrated DNA Technologies 50
BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries 51
AstraZeneca Enters Into Co-Development Agreement With Dako Denmark 52
Dako Denmark Enters Into An Agreement With OSI Pharma 53
Dako Enters Into Collaboration Agreement With Genentech 54
Advion BioSystems Signs An Agreement With Agilent Technologies 55
Millipore Enters Into Co-Development Agreement With Agilent Technologies 56
Dako Enters Into Co-Development Agreement With Bristol-Myers 57
Agendia Enters Into Co-Development Agreement With Agilent Technologies 58
Accelrys And Agilent Technologies Enter Into An Agreement 59
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 60
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 61
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 62
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 64
Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For US$250 Million 66
Agilent Technologies Completes Public Offering Of 5% Senior Notes For US$500 Million 68
Agilent Technologies Completes Public Offering Of 5.5% Senior Notes For US$500 Million 70
Agilent Technologies Completes Public Offering Of 4.45% Senior Notes For US$250 Million 72
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 74
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 76
Bruker Completes Acquisition Of Three Varian Product Lines From Agilent Technologies 78
Third Wave Technologies Acquires Velocity Patents From Agilent Technologies 80
Agilent Technologies To Acquire ABC Instrumentacion Analitica 81
Leica Biosystems Completes Acquisition Of Aperio Technologies 82
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 85
Agilent Technologies Completes Acquisition Of BioSystem Development 87
Agilent Technologies Acquires P.V.R. 88
Agilent Technologies Acquires Lab901 89
Agilent Technologies Completes Acquisition Of Varian 91
TOPTICA Photonics Acquires TILL Photonics From Agilent Technologies 93
Dako Denmark Acquires InstrumeC 94
Agilent Technologies Acquires MTS Nano Instruments From MTS Systems 95
Agilent Technologies Acquires TILL Photonics 96
Agilent Technologies, Inc., Key Competitors 97
Agilent Technologies, Inc., Key Employees 97
Agilent Technologies, Inc., Subsidiaries 100

List of Figures

Agilent Technologies, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 7
Agilent Technologies, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 8
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 9
Agilent Technologies, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 10

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 345038, price: INR 15226, GlobalData

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online